CIK 0001006045 · Non-accelerated filer<br>Smaller reporting company
IRIDEX CORP
Sign in to watch- Ticker
- IRIX
- Exchange
- Nasdaq
- Industry
- Electromedical & Electrotherapeutic Apparatus
- FY end
- Jan 3
- Incorporated
- DE
- Entity type
- operating
- EIN
- 770210467
- Phone
- 6509404700
- Business address
- 1212 TERRA BELLA AVE, MOUNTAIN VIEW, CA, 94043
- 4 Open-market buy Chief Financial Officer bought 1,005 shares at an average $1.35 ($1,356)
- 4 Open-market buy Chief Financial Officer bought 1,000 shares at an average $1.28 ($1,283)
- 4 Open-market buy Chief Financial Officer bought 1,000 shares at an average $1.26 ($1,258)
- 4 Open-market buy Chief Financial Officer bought 1,000 shares at an average $1.25 ($1,245)
- 4 Open-market buy Chief Financial Officer bought 1,000 shares at an average $1.22 ($1,220)
- 4 Open-market buy Chief Financial Officer bought 2,000 shares at an average $1.25 ($2,490)
- 4 Open-market buy Chief Financial Officer bought 1,000 shares at an average $1.18 ($1,184)
- 4 Open-market buy Chief Financial Officer bought 3,000 shares at an average $1.17 ($3,499)
- 4 Open-market buy Director bought 12,024 shares at $1.18 ($14,229)
- 4 Open-market buy Chief Financial Officer bought 1,500 shares at an average $1.18 ($1,767)
- 4 Open-market buy Chief Financial Officer bought 1,500 shares at an average $1.17 ($1,755)
- 4 Shares withheld for taxes President and CEO gave up 4,243 shares (to pay taxes)
- 4/A Derivatives Options or other derivatives
- 4/A Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4/A Grant or award Chief Financial Officer acquired 22,500 shares (grant or award)
- 4/A Grant or award President and CEO acquired 33,370 shares (grant or award)
- 4 Grant or award Chief Financial Officer acquired 22,500 shares (grant or award)
- 4 Grant or award President and CEO acquired 33,370 shares (grant or award)
Page 4 of 31 · 608 filings